Radich J - Search Results

1

Systematic assessment of decision-analytic models for chronic myeloid leukemia.

Rochau U, Schwarzer R, Jahn B, Sroczynski G, Kluibenschaedl M, Wolf D, Radich J, Brixner D, Gastl G, Siebert U. Rochau U, et al. Among authors: radich j. Appl Health Econ Health Policy. 2014 Apr;12(2):103-15. doi: 10.1007/s40258-013-0071-8. Appl Health Econ Health Policy. 2014. PMID: 24385259 Review.

2

Optimizing timing of secondary tyrosine kinase therapy in chronic myeloid leukemia.

Radich JP. Radich JP. Clin Lymphoma Myeloma. 2008 Mar;8 Suppl 3:S89-94. doi: 10.3816/CLM.2008.s.004. Clin Lymphoma Myeloma. 2008. PMID: 19254886 Review.

3

Chronic myeloid leukemia 2010: where are we now and where can we go?

Radich JP. Radich JP. Hematology Am Soc Hematol Educ Program. 2010;2010:122-8. doi: 10.1182/asheducation-2010.1.122. Hematology Am Soc Hematol Educ Program. 2010. PMID: 21239781 Review.

4

Medical decision analysis for first-line therapy of chronic myeloid leukemia.

Rochau U, Sroczynski G, Wolf D, Schmidt S, Conrads-Frank A, Jahn B, Saverno K, Brixner D, Radich J, Gastl G, Siebert U. Rochau U, et al. Among authors: radich j. Leuk Lymphoma. 2014 Aug;55(8):1758-67. doi: 10.3109/10428194.2013.858149. Epub 2014 Feb 6. Leuk Lymphoma. 2014. PMID: 24160847

5

Structure, function, and resistance in chronic myeloid leukemia.

Radich J. Radich J. Cancer Cell. 2014 Sep 8;26(3):305-306. doi: 10.1016/j.ccr.2014.08.010. Cancer Cell. 2014. PMID: 25203318 Free article.

6

Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.

Rochau U, Sroczynski G, Wolf D, Schmidt S, Jahn B, Kluibenschaedl M, Conrads-Frank A, Stenehjem D, Brixner D, Radich J, Gastl G, Siebert U. Rochau U, et al. Among authors: radich j. Leuk Lymphoma. 2015;56(8):2315-25. doi: 10.3109/10428194.2014.982635. Epub 2015 Jan 14. Leuk Lymphoma. 2015. PMID: 25393806

7

Integrating current treatment options for TKI-resistant chronic myeloid leukemia.

Radich JP, Shah NP, Mauro MJ. Radich JP, et al. Clin Adv Hematol Oncol. 2014 Jul;12(7 Suppl 13):3-17, 1. Clin Adv Hematol Oncol. 2014. PMID: 25768408

8

Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis.

Rochau U, Kluibenschaedl M, Stenehjem D, Kuan-Ling K, Radich J, Oderda G, Brixner D, Siebert U. Rochau U, et al. Among authors: radich j. Leuk Res Treatment. 2015;2015:982395. doi: 10.1155/2015/982395. Epub 2015 Dec 10. Leuk Res Treatment. 2015. PMID: 26783469 Free PMC article.

9

Predictors of tyrosine kinase inhibitor adherence trajectories in patients with newly diagnosed chronic myeloid leukemia.

Clark SE, Marcum ZA, Radich JP, Bansal A. Clark SE, et al. J Oncol Pharm Pract. 2021 Dec;27(8):1842-1852. doi: 10.1177/1078155220970616. Epub 2020 Nov 11. J Oncol Pharm Pract. 2021. PMID: 33175653 Free PMC article.

10

Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia.

Radich JP, Olavarria E, Apperley JF. Radich JP, et al. Hematol Oncol Clin North Am. 2004 Jun;18(3):685-702, x. doi: 10.1016/j.hoc.2004.03.013. Hematol Oncol Clin North Am. 2004. PMID: 15271400 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters